Attached files
file | filename |
---|---|
EX-16.1 - EXHIBIT 16.1 - China Health Industries Holdings, Inc. | exhibit16-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 12, 2017
CHINA HEALTH INDUSTRIES HOLDINGS,
INC.
(Exact name of Company as specified in
charter)
Delaware | 000-51060 | 86-0827216 |
(State or other jurisdiction | (Commission File No.) | (IRS Employer |
of Incorporation) | Identification No.) |
168 Binbei Street, Songbei District, Harbin City
Heilongjiang Province, Peoples Republic of China 150028 |
(Address of principal executive offices) (Zip Code) |
Companys telephone number, including area code: 86-451-88100688
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)
[ ] Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e -4(c))
Item 4.01. | Changes in Registrants Certifying Accountant. |
On January 12, 2017, China Health Industries Holdings, Inc., a corporation incorporated under the laws of the State of Delaware (the Company) dismissed CANUSWA ACCOUNTING & TAX SERVICES INC. (CANUSWA) as the Companys independent registered public accounting firm. The decision to dismiss CANUSWA was approved by the Companys sole director.
The principal accountants reports of CANUSWA on the financial statements of the Company as of and for the fiscal years ended June 30, 2016 and 2015 did not contain any adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles.
During the Companys two most recent fiscal years and the subsequent interim period through January 12, 2017, there were no disagreements with CANUSWA on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement(s) if not resolved to CANUSWAs satisfaction would have caused it to make reference to the subject matter of the disagreement(s) in connection with its report. During the Companys two most recent fiscal years and the subsequent interim period through January 12, 2017, there were no reportable events of the type described in Item 304(a)(1)(v) of Regulation S-K.
The Company provided CANUSWA with a copy of the foregoing disclosure and requested CANUSWA to furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the statements made therein. A copy of such letter, dated January 12, 2017, furnished by CANUSWA, is filed as Exhibit 16.1 to this Form 8-K.
On January 12, 2017, the Companys sole director approved the engagement of Centurion ZD CPA Limited (Centurion) as the Companys new independent registered public accounting firm.
During the Companys two most recent fiscal years and the subsequent interim period through January 12, 2017, neither the Company nor anyone on its behalf consulted with Centurion regarding (i) the application of accounting principles to a specified transaction, either completed or proposed; the type of audit opinion that might be rendered on the Company's financial statements, and neither a written report nor oral advice was provided that Centurion concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and its related instructions) or a reportable event (as described in Item 304(a)(1)(v) of Regulation S-K).
Item 9.01. | Financial Statements and Exhibits. |
(d) |
Exhibits |
16.1 | Letter from CANUSWA dated January 12, 2017 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 12, 2017
CHINA HEALTH INDUSTRIES HOLDINGS, INC. | |
By: | /s/ Xin Sun |
Name: | Xin Sun |
Title: | Chief Executive Officer and Chief Financial Officer |